{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,26]],"date-time":"2024-08-26T07:46:20Z","timestamp":1724658380348},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"36","license":[{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,9,21]]},"DOI":"10.1093\/eurheartj\/ehac497","type":"journal-article","created":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:44:10Z","timestamp":1663793050000},"page":"3371-3375","source":"Crossref","is-referenced-by-count":5,"title":["Pulmonary hypertension, sarcoidosis, and inflammatory and dilated cardiomyopathy: new light shed on prevalence, mechanisms, and treatment"],"prefix":"10.1093","volume":"43","author":[{"given":"Filippo","family":"Crea","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine , Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome , Italy"},{"name":"Department of Cardiovascular and Pulmonary Sciences, Catholic University of the Sacred Heart , Rome , Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,9,21]]},"reference":[{"key":"2022092120401279300_ehac497-B1","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1093\/eurheartj\/ehab491","article-title":"Home management or hospital admission for low-risk pulmonary embolism? Clinical scores versus pragmatic assessment","volume":"42","author":"Becattini","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B2","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B3","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1093\/eurheartj\/ehab314","article-title":"Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome","volume":"42","author":"Mir\u00f3","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B4","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/eurheartj\/ehab329","article-title":"Right ventricle assessment in patients with pulmonary embolism at low risk for death based on clinical models: an individual patient data meta-analysis","volume":"42","author":"Becattini","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B5","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1093\/eurheartj\/ehab354","article-title":"Right ventricle dysfunction in patients with acute pulmonary embolism supposedly at low risk for death: when evidence-based medicine rescues clinical practice","volume":"42","author":"Bertoletti","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B6","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1093\/eurheartj\/ehac206","article-title":"Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study","volume":"43","author":"Valerio","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B7","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1093\/eurheartj\/ehac170","article-title":"FOCUS on sequelae of acute pulmonary embolism: does it pay off?","volume":"43","author":"Lang","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B8","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1093\/eurheartj\/ehab688","article-title":"Takayasu arteritis-associated pulmonary hypertension","volume":"42","author":"Fukumoto","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B9","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1093\/eurheartj\/ehab599","article-title":"Clinical features and survival in Takayasu\u2019s arteritis-associated pulmonary hypertension: a nationwide study","volume":"42","author":"Jiang","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B10","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1093\/eurheartj\/ehaa780","article-title":"Proof that exercise works, now it\u2019s time for optimizing delivery to our patients with pulmonary hypertension","volume":"42","author":"La Gerche","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B11","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1093\/eurheartj\/ehac389","article-title":"Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial","volume":"43","author":"Dachs","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B12","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1093\/eurheartj\/ehac387","article-title":"Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?","volume":"43","author":"Bauersachs","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B13","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1093\/eurheartj\/ehac184","article-title":"Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiological implications","volume":"43","author":"Omote","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B14","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1093\/eurheartj\/ehac176","article-title":"Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?","volume":"43","author":"Hoeper","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B15","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1093\/eurheartj\/ehab360","article-title":"Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Lam","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehaa968","article-title":"Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Packer","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B17","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurheartj\/ehaa1007","article-title":"Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Butler","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/eurheartj\/ehaa943","article-title":"Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes","volume":"42","author":"Abraham","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B19","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1093\/eurheartj\/ehab560","article-title":"Effect of dapagliflozin on ventricular arrhythmias, resuscitated cardiac arrest, or sudden death in DAPA-HF","volume":"42","author":"Curtain","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B20","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/eurheartj\/ehab530","article-title":"Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial","volume":"43","author":"Oyama","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B21","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/eurheartj\/ehab092","article-title":"Dapagliflozin, advanced chronic kidney disease, and mortality: new insights from the DAPA-CKD trial","volume":"42","author":"Marx","year":"2021","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B22","doi-asserted-by":"crossref","first-page":"3435","DOI":"10.1093\/eurheartj\/ehac320","article-title":"Uric acid and sodium\u2013glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial","volume":"43","author":"Doehner","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B23","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1093\/eurheartj\/ehac415","article-title":"Serum uric acid lowering with empagliflozin in heart failure with reduced ejection fraction: a sweet added benefit?","volume":"43","author":"Mackenzie","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B24","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/eurheartj\/ehac323","article-title":"Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry","volume":"43","author":"Nabeta","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B25","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1093\/eurheartj\/ehac411","article-title":"Cardiac sarcoidosis: growing evidence in risk stratification","volume":"43","author":"Meder","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B26","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1093\/eurheartj\/ehac348","article-title":"Immunosuppressive therapy in virus-negative inflammatory cardiomyopathy: 20-year follow-up of the TIMIC trial","volume":"43","author":"Chimenti","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B27","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1093\/eurheartj\/ehac412","article-title":"Advanced diagnostics in inflammatory cardiomyopathy for personalized therapeutic decision-making","volume":"43","author":"Schultheiss","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B28","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/eurheartj\/ehac305","article-title":"Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy","volume":"43","author":"Perea-Gil","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B29","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1093\/eurheartj\/ehac397","article-title":"Activation of an accessory pathway of glucose metabolism to treat dilated cardiomyopathy","volume":"43","author":"Eschenhagen","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B30","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1093\/eurheartj\/ehac418","article-title":"Atrial functional assessment at rest and during exercise stress in left ventricular diastolic dysfunction","volume":"43","author":"Backhaus","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B31","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1093\/eurheartj\/ehac207","article-title":"Cardiac magnetic resonance identifies raised left ventricular filling pressure: prognostic implications","volume":"43","author":"Garg","year":"2022","journal-title":"Eur Heart J"},{"key":"2022092120401279300_ehac497-B32","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/eurheartj\/ehac420","article-title":"Importance of cardiac magnetic resonance imaging assessment of left ventricular filling pressure at resting state","volume":"43","author":"Garg","year":"2022","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/36\/3371\/45955608\/ehac497.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/36\/3371\/45955608\/ehac497.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T20:44:51Z","timestamp":1663793091000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/36\/3371\/6708324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,21]]},"references-count":32,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2022,9,21]]},"published-print":{"date-parts":[[2022,9,21]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehac497","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,9,21]]},"published":{"date-parts":[[2022,9,21]]}}}